ARTICLE
22 January 2010

Obtaining DEA Special Emergency Waivers For Sending Narcotics To Haiti

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
This alert provides important information regarding the exportation of narcotics and other controlled substances to Haiti in response to the devastating earthquake that occurred on January 12, 2010.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Maria Currier is a Partner and Liliana Vidal is an Associate in our Miami office

This alert provides important information regarding the exportation of narcotics and other controlled substances to Haiti in response to the devastating earthquake that occurred on January 12, 2010.

The exportation of certain controlled substances is regulated and restricted under the Controlled Substances Import and Export Act, 21 U.S.C. Section 958 (Act). In order to expedite the assistance being offered by hospitals and other providers, the Department of Justice and the Drug Enforcement Administration (DEA) are facilitating the process for exporting controlled substances during this disaster.

Hospitals and other providers seeking to send controlled substances to Haiti will need to obtain special emergency waivers of the export requirements and restrictions of the Act from the DEA. In order to do so, your facilities should contact:

Daniel Gillen
Chief of the Import/Export Unit of the DEA
E-mail: daniel.j.gillen@usdoj.gov
Phone: 202.307.7969
Fax: 202.307.4702
Mobile: 202.270.2430

The DEA will require certain information to be provided prior to the issuance of such waivers, including:

  • the names of doctors traveling to Haiti
  • the DEA numbers of such doctors
  • a list of quantities and dosages of the controlled substances being exported
  • plans for distribution of the controlled substances upon exportation (e.g., whether the controlled substances will be distributed at a clinic, via UN personnel, etc.).

www.hklaw.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More